← Back to Search

Population Management Platform for Colorectal Cancer Screening

N/A
Recruiting
Led By Adjoa Anyane-Yeboa, MD, MPH
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights

Summary

This trial will use a combination of focus groups and data analysis to examine how well a new population management platform works in primary care clinics.

Who is the study for?
This pilot study is for staff members at partnering community health centers (CHCs) involved in colorectal cancer screening. Eligible participants include administrative leaders, population health managers, data analysts, quality improvement staff, nurses, and providers who are 18 years or older.
What is being tested?
The study is testing an Implementation Science Strategy to remove obstacles from colorectal cancer screening processes. It involves focus groups with CHC staff and analysis of electronic health records (EHR) and data from a management platform.
What are the potential side effects?
Since this trial focuses on implementing strategies rather than medical treatments, it does not involve typical medication side effects. However, there may be indirect impacts related to workflow changes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
1: Acceptability of Implementation Strategies
2: Feasibility of Implementation Strategies
3: Appropriateness of Implementation Strategies
Secondary study objectives
: CRC Screening Rates

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Introduction of Implementation StrategiesExperimental Treatment1 Intervention
The investigators will determine the best intervention and strategy (and thus implementers) based on high ranking barriers/facilitators identified in focus groups. A minimum of 2 implementation strategies will be developed and implemented at each level (patient, provider, system) at each site that considers (1) implementation strategy; (2) mechanism in which the strategy impacts the identified determinant (3) the determinant; (4) moderators that may influence the impact of the strategy; (5) the preconditions necessary for successful implementation; and (6) implementation outcomes affected. Each community health center (CHC) will serve as its own separate subject, and individual strategies will be tested using single case experimental design (SCED) at each CHC using component analysis to rapidly test and optimize our strategies. In SCED each subject serves as their own control, an intervention is systematically introduced and withdrawn, and the effects of the intervention are measured.
Group II: Withdrawal of Implementation StrategiesActive Control1 Intervention
In SCED each subject serves as their own control, an intervention is systematically introduced and withdrawn, and the effects of the intervention are measured.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,842 Previous Clinical Trials
41,002,998 Total Patients Enrolled
Massachusetts General HospitalLead Sponsor
2,993 Previous Clinical Trials
13,230,719 Total Patients Enrolled
Adjoa Anyane-Yeboa, MD, MPHPrincipal InvestigatorMass General Hospital // Harvard Medical School
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top